Baxdela Tablet
Product Images NDC 70842-101

This is information about a medication called Baxdela that comes in tablet form with each tablet containing 450 mg of delafloxacin. The package insert should be reviewed for proper dosage instructions and the accompanying prescription information should be read. The tablets also contain other ingredients such as crospovidons, sodium bicarbonates, and microcrystalline. The medication is distributed by Meiita Therapautis, LLC from Lincolnshis, IL. Storage instructions suggest keeping the medication at a temperature between 20°C to 25°C (B8°F to 77°F) with allowed excursions from 15°C to 30°C (B9°F to BE°F). This medication is only available with a prescription from a licensed healthcare provider.*

Dosage and usage information is available on the package insert for NDC 70842-102:01. Each 300mg vial of delafloxacin must be reconstituted with 105mL of either DSW or 0% sodium chloride for injection, and can subsequently be diluted with either D5W or 0.9% sodium chloride. The vial contains 200mg sulfobutyl ether-p-cyclodextrin as well as other excipients, and storage should be between 20°C to 25°C (66°F to 77°F) with permitted excursions between 15°C to 0°C (59°F to 86°F). This medication is only for intravenous infusion.*

Baxdela (delafloxacin) is an injection medication used in the treatment of infections. Each vial contains 300 mg of delafloxacin and is meant for a single use. The dosage and usage information must be read from the accompanying prescription. The medication must be distributed and diluted following specific instructions. Baxdela should be stored in temperatures ranging from 20°C to 25°C and discarded if unusable. Other information regarding the medication, such as excipients, is not available or illegible due to poor quality .*